Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
——
Kenvue logo
KenvueKVUE
——
Cardinal Health logo
Cardinal HealthCAH
——
Baxter International logo
Baxter InternationalBAX
——

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.24B-34.1%

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's indefinite- lived intangible impairment?
Prestige Consumer Healthcare (PBH) reported indefinite- lived intangible impairment of $2.59B in Q4 2025.
How has Prestige Consumer Healthcare's indefinite- lived intangible impairment changed year-over-year?
Prestige Consumer Healthcare's indefinite- lived intangible impairment increased by 0.3% year-over-year, from $2.58B to $2.59B.
What is the long-term trend for Prestige Consumer Healthcare's indefinite- lived intangible impairment?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's indefinite- lived intangible impairment has grown at a -0.9% compound annual growth rate (CAGR), from $2.67B to $2.57B.